Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Taiwan says China blocked deal with BioNTech for COVID-19 shots

Wed, 26th May 2021 08:36

(Adds Taiwanese official seeking U.S. and EU help)

By Yimou Lee and Ben Blanchard

TAIPEI, May 26 (Reuters) - Taiwan directly accused China for
the first time on Wednesday of blocking a deal with Germany's
BioNTech SE for COVID-19 vaccines, in an escalating
war of words after Beijing offered the shots to the island via a
Chinese company.

Taiwan has millions of shots on order, from AstraZeneca Plc
and Moderna Inc, but has received only slightly
more than 700,000 to date, and has only been able to vaccinate
about 1% of its population as COVID-19 cases surge.

While Taiwan has previously said it had been unable to sign
a final contract with BioNTech, it had only implied that Chinese
pressure was to blame.

China claims Taiwan as its territory and frequently puts
pressure on countries and firms to curtail their dealings with
the island.

President Tsai Ing-wen told a meeting of her ruling
Democratic Progressive Party that orders for the AstraZeneca and
Moderna shots had been "smoothly" booked.

"As for Germany's BioNTech, we were close to completing the
contract with the original German plant, but because of China's
intervention, up to now there's been no way to complete it," she
said.

Taiwan, which has a population of more than 23 million
people, had bought nearly 30 million shots, Tsai said, without
giving details.

BioNTech, which sells its vaccine in partnership with Pfizer
Inc, declined to comment on Tsai's remarks, but added
"we are supportive of global vaccine supply".

China has denied trying to block vaccines for Taiwan and has
offered to provide them to the island as a goodwill gesture.

APPEALS FOR U.S., EU ASSISTANCE

Lily L.W. Hsu, secretary-general of Taiwan's Foreign
Ministry, called the Chinese offer "very divisive."

At an online event hosted by the German Marshall Fund of the
United States that also involved a U.S. and an EU official, Hsu
said Taiwan was developing its own vaccine, but the earliest
that would be ready for use was July. She repeated calls Taiwan
has made for U.S and EU assistance.

"Because of the recent outbreak we desperately need vaccines
... we do need assistance in getting vaccines before our
domestic vaccine is ready for use, she said.

The top U.S. diplomat in Taipei, Brent Christensen, said on
Wednesday he was confident Taiwan could control its spike in
COVID-19 cases, noting its infection numbers remained quite low.
He said the United States and Taipei were in talks on vaccines
but did not say shots were on the way.

China's Shanghai Fosun Pharmaceutical Group Co Ltd
said on Saturday it was willing to provide Taiwan
with BioNTech COVID-19 vaccines.

Fosun signed a deal with BioNTech to exclusively develop and
commercialise the vaccine developed using BioNTech's mRNA
technology in mainland China, Hong Kong, Macau and Taiwan.

But Tsai said the island would only buy directly from the
original manufacturers, or discuss purchases with them via the
COVAX global vaccine sharing scheme.

"Only by negotiating with the original manufacturer can you
obtain the original manufacturer's direct guarantee and
responsibility for quality and safety, so as to avoid legal and
political risks," she said.

Fosun did not respond to requests for comment.

China's foreign ministry said Taiwan's channels to receive
vaccines from them were "smooth", while China's Taiwan Affairs
Office said Taipei was using excuses to stop the shots.

China was "happy to see" Fosun's willingness to provide
vaccines to Taiwan, the Chinese office added.

Several Taiwan politicians have said the need for the Fosun
shots was so urgent the government should bring them in.

But Taiwan's Health Minister Chen Shih-chung told a daily
news briefing Taiwan had seen no supporting documentation about
Fosun's version of the vaccine.

"Bring out the official documents and we can talk about it
again."
(Reporting by Ben Blanchard and Yimou Lee in Taipei and David
Brunnstrom and Michael Martina in Washington; Editing by
Christopher Cushing, Robert Birsel and Bill Berkrot)

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.